BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9059138)

  • 1. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial.
    Egsmose C; Hansen TM; Andersen LS; Beier JM; Christensen L; Ejstrup L; Peters ND; van der Heijde DM
    Ann Rheum Dis; 1997 Jan; 56(1):32-6. PubMed ID: 9059138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
    Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.
    Faarvang KL; Egsmose C; Kryger P; Pødenphant J; Ingeman-Nielsen M; Hansen TM
    Ann Rheum Dis; 1993 Oct; 52(10):711-5. PubMed ID: 7903034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study.
    Kvien TK; Gaston JS; Bardin T; Butrimiene I; Dijkmans BA; Leirisalo-Repo M; Solakov P; Altwegg M; Mowinckel P; Plan PA; Vischer T;
    Ann Rheum Dis; 2004 Sep; 63(9):1113-9. PubMed ID: 15308521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
    Clegg DO; Reda DJ; Abdellatif M
    Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphasalazine in psoriatic arthritis: a randomized, multicentre, placebo-controlled study.
    Combe B; Goupille P; Kuntz JL; Tebib J; Lioté F; Bregeon C
    Br J Rheumatol; 1996 Jul; 35(7):664-8. PubMed ID: 8670601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
    Scott DL; Smolen JS; Kalden JR; van de Putte LB; Larsen A; Kvien TK; Schattenkirchner M; Nash P; Oed C; Loew-Friedrich I;
    Ann Rheum Dis; 2001 Oct; 60(10):913-23. PubMed ID: 11557646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study.
    Dougados M; vam der Linden S; Leirisalo-Repo M; Huitfeldt B; Juhlin R; Veys E; Zeidler H; Kvien TK; Olivieri I; Dijkmans B
    Arthritis Rheum; 1995 May; 38(5):618-27. PubMed ID: 7748217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
    Dougados M; Boumier P; Amor B
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis.
    Ciconelli RM; Ferraz MB; Visioni RA; Oliveira LM; Atra E
    Br J Rheumatol; 1996 Feb; 35(2):150-4. PubMed ID: 8612028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.
    Clegg DO; Reda DJ; Weisman MH; Cush JJ; Vasey FB; Schumacher HR; Budiman-Mak E; Balestra DJ; Blackburn WD; Cannon GW; Inman RD; Alepa FP; Mejias E; Cohen MR; Makkena R; Mahowald ML; Higashida J; Silverman SL; Parhami N; Buxbaum J; Haakenson CM; Ward RH; Manaster BJ; Anderson RJ; Henderson WG
    Arthritis Rheum; 1996 Dec; 39(12):2021-7. PubMed ID: 8961907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
    van Rossum MA; Fiselier TJ; Franssen MJ; Zwinderman AH; ten Cate R; van Suijlekom-Smit LW; van Luijk WH; van Soesbergen RM; Wulffraat NM; Oostveen JC; Kuis W; Dijkstra PF; van Ede CF; Dijkmans BA
    Arthritis Rheum; 1998 May; 41(5):808-16. PubMed ID: 9588731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study.
    Farr M; Kitas GD; Waterhouse L; Jubb R; Felix-Davies D; Bacon PA
    Br J Rheumatol; 1990 Feb; 29(1):46-9. PubMed ID: 1968355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphasalazine in the management of psoriatic arthritis.
    Fraser SM; Hopkins R; Hunter JA; Neumann V; Capell HA; Bird HA
    Br J Rheumatol; 1993 Oct; 32(10):923-5. PubMed ID: 8104656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.